• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

EMA

Posted inIn the Pipeline, Infections, New Drugs, Regulatory

Shingrix: Excellent Vaccine Against Shingles

by Julia Mardi and Timur Burkhanayev April 22, 2024April 22, 2024

Shingrix for robust and long-lasting prevention of herpes zoster and postherpetic neuralgia in all adults.

Posted inInfections, New Drugs, Regulatory

mResvia, Arexvy, Abrysvo: Top Quality RSV Vaccines

by Nik Resovski and Timur Burkhanayev April 19, 2024April 19, 2024

It’s time to bury respiratory syncytial virus in the abyss of immunization fire.

Posted inNew Drugs, Oncology, Regulatory

Datroway/Datverzo: Groundbreaking New Way to Treat Lung Cancer

by Julia Mardi and Mark Gubar March 27, 2024March 27, 2024

Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.

Posted inMetabolism, New Drugs, Rare/Orphan Diseases, Regulatory

Lenmeldy/Libmeldy: Most Expensive Drug in the World

by Mark Gubar March 21, 2024April 2, 2024

Atidarsagen autotemcel is a gene therapy for metachromatic leukodystrophy (MLD).

givinostat
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Duvyzat: Givinostat for Duchenne Muscular Dystrophy Treatment

by Mark Gubar March 20, 2024April 2, 2024

Oral givinostat delays the progression of DMD.

Posted inNew Drugs, Oncology, Regulatory

Tevimbra: Immuno-Oncologic Treatment for Esophageal Cancer

by Julia Mardi March 19, 2024April 2, 2024

Tislelizumab for the treatment of unresectable or metastatic esophageal squamous cell carcinoma.

brain
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Relyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment

by Tanya von Reuss September 29, 2022September 30, 2022

Amylyx Pharmaceuticals proposed mixture of sodium phenylbutyrate and tauroursodeoxycholic acid for ALS treatment.

Posts pagination

1 2 3 4 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×